Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. respiratory tracts
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Respiratory Tracts Articles & Analysis

54 news found

Newborn Snoring: causes, effects, and solutions for peaceful sleep

Newborn Snoring: causes, effects, and solutions for peaceful sleep

What is Newborn Snoring? Oftentimes, newborns breathe noisily when they sleep. It may be caused due to extra mucus or dryness in their tiny nasal passages. However, if you notice your newborn baby actually snoring on a regular basis, consult with a doctor. If your snoring is causing issues with your partner or his/her snoring is irritating you at night, it is important that you seek timely ...

ByTannerMedico A/S - Asonor


Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

COVID-19 RT-qPCR Detection Kit RUO Combining expertise in diagnostics, therapeutics, and vaccination fighting against the COVID-19 (SARS-CoV-2) pandemic, scientists at Alfa Chemistry have specifically developed the COVID-19 RT-qPCR Detection Kit RUO for human respiratory tract specimens. The kit is compatible with standard RT-qPCR machines and is characterized ...

ByAlfa Chemistry


BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

Funding from the BARDA Division of Research, Innovation, and Ventures (DRIVe) enabled the company to reformulate LMN-301, previously developed for oral delivery, and to evaluate its potential as an anti-viral therapeutic delivered to the respiratory tract, the primary site of SARS-CoV-2 infection. The efficacy of the intranasal formulation was evaluated by ...

ByLumen Bioscience, Inc.


MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

The most common (≥25%) nonhematologic treatment-emergent AEs of any grade were diarrhea (43%), respiratory tract infection (41%), asthenic conditions (38%), musculoskeletal pain (32%), constipation (30%), nausea (29%), dizziness (27%) and abdominal pain (26%). ...

ByMorphoSys AG


Prof. Krestin Joins Fluidda’S Board of Directors

Prof. Krestin Joins Fluidda’S Board of Directors

FRI SUPPORTS MOVE TO DATA-DRIVEN RESPIRATORY MEDICINE Radiologists’ interpretation of images has traditionally been something of an art. ...

ByFluidda


Dr. Davies-Cutting Brings Industry Leading Technical Expertise to Nob Hill Therapeutics

Dr. Davies-Cutting Brings Industry Leading Technical Expertise to Nob Hill Therapeutics

“Our initial focus will be on the treatment of lower respiratory tract infections, for which there remains a significant unmet need. ...

ByNob Hill Therapeutics


Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

– New Data Further Support Potential for Patisiran to be an Effective Treatment for Cardiomyopathy of ATTR Amyloidosis – – Data from Exploratory Endpoints, Including Cardiac Biomarkers and Imaging, Suggest Favorable Impact of Patisiran on Measures of Cardiac Stress, Injury, Structure, and Function at Month 12 – – Treatment with Patisiran Demonstrated Generally ...

ByAlnylam Pharmaceuticals, Inc.


Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

– Company to Webcast Investor Event on September 30th at 8:00 p.m. ET – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 13, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company will present additional data from the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for the treatment ...

ByAlnylam Pharmaceuticals, Inc.


Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO

Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO

There are over 250 million people who suffer from lower respiratory tract infections (LTRI) every year and it is the 5th leading cause of death globally. ...

ByNob Hill Therapeutics


An Investigator Initiated Clinical Trial of Inhaled Bofutrelvir for Post-Exposure Prophylaxis in Close Contacts of COVID-19 Patients

An Investigator Initiated Clinical Trial of Inhaled Bofutrelvir for Post-Exposure Prophylaxis in Close Contacts of COVID-19 Patients

Data from preclinical studies has shown that Bofutrelvir administered by inhalation is safe and tolerable in rats and dogs, and PK profile shown that Bofutrelvir has significant higher drug exposure in respiratory tract and lungs than that in plasma. FB2001 (generic name: Bofutrelvir) is a SARS-CoV-2 3CL protease inhibitor under clinical development for ...

ByFrontier Biotechnologies Inc.


OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

” About Unyvero Lower Respiratory Tract and Hospitalized Pneumonia Panels The Unyvero Hospitalized Pneumonia (HPN) panel detects 21 clinically relevant pathogens and 17 antibiotic resistance markers in less than five hours directly from native specimens with only around two minutes of hands-on time, compared to routine bacterial cultures that can take up ...

ByOpGen, Inc.


STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

Biocompatibility evaluation of breathing gas pathways in medical devices is a powerful tool for assessing contaminants from the air emitted from the device for Volatile Organic Compounds (VOCs) and particulate matter when the gas pathway is intended to contact a patient’s respiratory tract. STEMart now offers various services for Testing of Breathing Gas ...

BySTEMart


Amgen And Lance Bass Partner To Encourage People To Do A `Double Take` To Recognize The Early Signs Of Psoriatic Arthritis

Amgen And Lance Bass Partner To Encourage People To Do A `Double Take` To Recognize The Early Signs Of Psoriatic Arthritis

THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...

ByAmgen Inc.


Etienne Jornod, Om Pharma‘S Executive Chairman Receives Swiss Biotech Success Stories Award 2022

Etienne Jornod, Om Pharma‘S Executive Chairman Receives Swiss Biotech Success Stories Award 2022

OM Pharma’s transformation will include new research and development aimed at extending the use of bacterial lysates for the prevention and treatment of a wide range of immuno-inflammatory diseases that affect millions of children and adults, including asthma, atopic dermatitis, recurrent wheezing and other diseases of the respiratory and urinary tract ...

ByOM Pharma Ltd.


Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

Adverse events that were more commonly observed with Dupixent compared to placebo included injection site reactions (18% Dupixent, 13% placebo), viral upper respiratory tract infections (12% Dupixent, 10% placebo) and eosinophilia (7% Dupixent, 1% placebo). ...

ByRegeneron Pharmaceuticals Inc.


Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

It lives in humans and livestock and is commonly found in the upper respiratory tract and skin. Staphylococcus aureus is one of the leading causes of foodborne bacterial poisoning worldwide. ...

ByCreative Diagnostics


Altamira Therapeutics and Wellesta Expand Bentrio Marketing and Distribution Agreement to Include Two Additional Markets

Altamira Therapeutics and Wellesta Expand Bentrio Marketing and Distribution Agreement to Include Two Additional Markets

Together, this is designed to reduce the risk of upper respiratory tract viral infections and promote alleviation of allergic symptoms. ...

ByAuris Medical AG


Altamira Therapeutics and Avernus Pharma Collaborate for Marketing and Distribution of Bentrio in Gulf Countries

Altamira Therapeutics and Avernus Pharma Collaborate for Marketing and Distribution of Bentrio in Gulf Countries

Together, this is designed to reduce the risk of upper respiratory tract viral infections and promote alleviation of allergic symptoms. ...

ByAuris Medical AG


T,C&A Lab Declares Capability of Biomedical Materials Testing

T,C&A Lab Declares Capability of Biomedical Materials Testing

” More specifically, the testing range of T,C&A Lab encompasses the following: l Repair materials for the skeletal-muscle system such as bones, teeth, joints, and tendons l Soft tissue materials such as skin, esophagus, respiratory tract, bladder and other l Cardiovascular system materials such as artificial heart valves, blood vessels, and ...

ByAlfa Chemistry


Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen

Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen

Adverse reactions included cytokine release syndrome (75.8%), neutropenia (41.9%), thrombocytopenia (40.3%), anaemia (38.7%), fatigue (32.3%), leukopenia (27.4%), lymphopenia (16.1%), nausea (14.5%), headache (14.5%), hypophosphataemia (12.9%), and upper respiratory tract infection (11.3%) (aggregated until approval). Abecma U.S. ...

ByBristol Myers Squibb Corporate

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT